Your browser doesn't support javascript.
loading
Hybrid atrial fibrillation ablation.
van der Heijden, Claudia A J; Aerts, Luca; Chaldoupi, Sevasti-Marisevi; van Cruchten, Cas; Kawczynski, Michal; Heuts, Samuel; Bidar, Elham; Luermans, Justin G L M; Maesen, Bart.
  • van der Heijden CAJ; Department of Cardiothoracic Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Aerts L; Department of Cardiothoracic Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Chaldoupi SM; Department of Cardiology, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • van Cruchten C; Cardiovascular Research Institute (CARIM), Maastricht University, Maastricht, The Netherlands.
  • Kawczynski M; Department of Plastic Surgery, VieCuri Medical Center, Venlo, The Netherlands.
  • Heuts S; Department of Cardiothoracic Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Bidar E; Cardiovascular Research Institute (CARIM), Maastricht University, Maastricht, The Netherlands.
  • Luermans JGLM; Department of Cardiothoracic Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Maesen B; Cardiovascular Research Institute (CARIM), Maastricht University, Maastricht, The Netherlands.
Ann Cardiothorac Surg ; 13(1): 54-70, 2024 Jan 30.
Article en En | MEDLINE | ID: mdl-38380145
ABSTRACT
In this state-of-the art review on hybrid atrial fibrillation (AF) ablation, we briefly focus on the pathophysiology of AF, the rationale for the hybrid approach, its technical aspects and the efficacy and safety outcomes after hybrid AF ablation, both from meta-analyses and randomized control trial data. Also, we performed a systematic search to provide a provisional overview of real-world hybrid AF ablation efficacy and safety outcomes. Furthermore, we give an insight into the 'Maastricht approach', an approach that allows us to tailor the ablation procedure to the individual patient. Finally, we reflect on future perspectives with the objective to continue improving our thoracoscopic hybrid AF ablation approach. Based on the review of the available literature, we believe it is fair to state that thoracoscopic hybrid AF ablation is a valid alternative to catheter ablation for the treatment of patients with more persistent forms of AF.
Palabras clave